ATyr Pharma to Present at Upcoming Investor Conferences

SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its pro

GlobeNewswireMay 6 08:00 ET

Express News | HC Wainwright & Co. Reiterates Buy on ATyr Pharma, Maintains $35 Price Target

BenzingaMay 3 15:55 ET

RBC Capital Sticks to Their Buy Rating for ATyr Pharma (LIFE)

TipRanksMay 3 07:06 ET

Strong Buy Rating for ATyr Pharma as Efzofitimod Shows Promise and Financial Stability

TipRanksMay 3 06:26 ET

Express News | ATyr Pharma Inc: Believes Cash Runway to Be Sufficient to Fund Operations Through Filing of Bla for Efzofitimod in Pulmonary Sarcoidosis

ReutersMay 2 16:01 ET

Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000

04:00 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000

MT NewswiresMay 2 16:00 ET